CLINICAL-PHARMACOLOGY IN PATIENTS WITH EVOLVING MYOCARDIAL-INFARCTION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR PRODUCED BY RECOMBINANT DNA TECHNOLOGY

被引:92
|
作者
TIEFENBRUNN, AJ
ROBISON, AK
KURNIK, PB
LUDBROOK, PA
SOBEL, BE
机构
关键词
D O I
10.1161/01.CIR.71.1.110
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:110 / 116
页数:7
相关论文
共 50 条
  • [1] CORONARY THROMBOLYSIS WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH EVOLVING MYOCARDIAL-INFARCTION
    VANDEWERF, F
    LUDBROOK, PA
    BERGMANN, SR
    TIEFENBRUNN, AJ
    FOX, KAA
    DEGEEST, H
    VERSTRAETE, M
    COLLEN, D
    SOBEL, BE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (10): : 609 - 613
  • [2] TREATMENT OF ACUTE MYOCARDIAL-INFARCTION WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    GLAZIER, JJ
    CROWLEY, J
    CREMIN, D
    COLL, T
    DALY, K
    [J]. IRISH MEDICAL JOURNAL, 1989, 82 (03) : 111 - 114
  • [3] TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND RISK OF MYOCARDIAL-INFARCTION
    CIMMINIELLO, C
    [J]. LANCET, 1993, 342 (8862): : 48 - 49
  • [4] LIMITATION OF MYOCARDIAL-INFARCTION BY EARLY INFUSION OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    OROURKE, M
    BARON, D
    KEOGH, A
    KELLY, R
    NELSON, G
    BARNES, C
    RAFTOS, J
    GRAHAM, K
    HILLMAN, K
    NEWMAN, H
    HEALEY, J
    WOOLRIDGE, J
    RIVERS, J
    WHITE, H
    WHITLOCK, R
    NORRIS, R
    [J]. CIRCULATION, 1988, 77 (06) : 1311 - 1315
  • [6] ENDOGENOUS TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND RISK OF MYOCARDIAL-INFARCTION
    RIDKER, PM
    VAUGHAN, DE
    STAMPFER, MJ
    MANSON, JE
    HENNEKENS, CH
    [J]. LANCET, 1993, 341 (8854): : 1165 - 1168
  • [7] RANDOMIZED ANGIOGRAPHIC TRIAL OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR (ALTEPLASE) IN MYOCARDIAL-INFARCTION
    CARNEY, RJ
    MURPHY, GA
    BRANDT, TR
    DALEY, PJ
    PICKERING, E
    WHITE, HJ
    MCDONOUGH, TJ
    VERMILYA, SK
    TEICHMAN, SL
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 20 (01) : 17 - 23
  • [8] CORONARY THROMBOLYSIS WITH HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR PRODUCED BY RECOMBINANT DNA TECHNOLOGY
    VANDEWERF, F
    BERGMANN, SR
    FOX, KAA
    DEGEEST, H
    SOBEL, BE
    COLLEN, D
    [J]. CIRCULATION, 1983, 68 (04) : 185 - 185
  • [9] ANTIBODIES TO TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN SERUM OF PATIENTS TREATED WITH THE RECOMBINANT PROTEIN FOR ACUTE MYOCARDIAL-INFARCTION
    CUGNO, M
    BISIANI, G
    CICARDI, M
    MERLINI, PA
    SPINOLA, A
    AGOSTONI, A
    [J]. CLINICAL RESEARCH, 1994, 42 (02): : A193 - A193
  • [10] COMPARATIVE PROPERTIES OF 2 CLINICAL PREPARATIONS OF RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    GARABEDIAN, HD
    GOLD, HK
    LEINBACH, RC
    JOHNS, JA
    YASUDA, T
    KANKE, M
    COLLEN, D
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (03) : 599 - 607